(A) SiRNA-mediated knockdown of KDM4A reflected the phenotype seen with QC6352 treatment in WiT49 and HEK293 cells by increasing the proportion of cells in the S-phase. Of note, SiRNA-mediated knockdown of KDM4A (but not KDM4B or KDM4C) induced aneuploidy in WiT49 and HEK293 cells (green and yellow peaks).( B) Comet assay (quantitation shown in manuscript Figure 5) demonstrated DNA damage (tails shown with white arrows) in WiT49 and HEK293 cells in response to siKDM4A. Doxorubicin (10nM) is shown as a positive control.
No takes yet. Share an insight, caveat, or question.
Pichavaram et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: